Paracodin (Dihydrocodeine Tartrate)

Dihydrocodeine tartrate, the active ingredient in Paracodin, is an opioid analgesic presented as a tablet for oral use. It is used to manage moderate pain and to relieve coughing in adults. GNH USA supplies Paracodin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Paracodin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Paracodin (dihydrocodeine) acts on the central nervous system to provide relief in several pain‑related and cough‑related conditions.

- Moderate acute pain: helps relieve pain where non‑opioid analgesics are insufficient. - Chronic non‑cancer pain: used as part of a stepped‑care approach for ongoing pain management. - Cough suppression: reduces the urge to cough in cases of irritating or persistent cough. - Post‑operative pain: provides short‑term relief after surgical procedures. - Dental pain: alleviates pain associated with dental extractions or procedures.

Paracodin may cause a range of adverse reactions, most of which are dose‑dependent and reversible.

Common Side Effects: - Drowsiness: feeling unusually sleepy or fatigued. - Nausea: mild to moderate upset stomach. - Constipation: reduced bowel movements or hard stools. - Dizziness: light‑headed sensation, especially when standing quickly. - Dry mouth: reduced salivation leading to a parched feeling. - Itching: mild skin irritation or pruritus.

Serious or Rare Side Effects: - Respiratory depression: slowed or shallow breathing that may be life‑threatening. - Severe allergic reaction: rash, swelling, or difficulty breathing. - Dependence or addiction: potential for misuse with prolonged use. - Low blood pressure: sudden drop causing faintness. - Seizures: rare occurrence of convulsive episodes. - Liver dysfunction: abnormal liver enzymes or jaundice.

Paracodin should be used only under medical supervision, with attention to patient history and potential risks.

- Assess respiratory function: ensure adequate breathing before initiating therapy. - Review liver and kidney status: adjust use if organ impairment is present. - Avoid concurrent CNS depressants: limit use with alcohol, benzodiazepines, or other opioids. - Monitor for signs of dependence: watch for cravings or withdrawal symptoms. - Educate on constipation management: advise increased fluid and fiber intake. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Paracodin can interact with several drug classes, altering its efficacy or safety profile.

Major Interactions (Avoid): - Other opioids: combined use can increase risk of respiratory depression. - Benzodiazepines: may potentiate central nervous system depression. - MAO inhibitors: can cause severe hypotension or serotonin syndrome.

Moderate Interactions (Monitor Closely): - Antihistamines: may enhance drowsiness. - Antidepressants (SSRIs/SNRIs): potential for increased serotonin levels. - CYP3A4 inhibitors (e.g., erythromycin): may raise dihydrocodeine plasma concentrations.